| Original article |
|
|
|
|
|
Chemical Composition of the Essential Oil of Mastic Gum and their Antibacterial Activity Against Drug-Resistant Helicobacter pylori |
| Tomofumi Miyamoto1, Tadayoshi Okimoto2, Michihiko Kuwano3 |
1. Department of Natural Products Chemistry, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan;
2. Department of Gastroenterology, Oita University Faculty of Medicine, Oita, Japan;
3. Laboratory of Molecular Cancer Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan |
|
|
|
|
Abstract Mastic gum is derived from the tree named Pistacia lentiscus that is grown only in Island Hios of Greek. Since Mastic was first reported to kill Helicobacter pylori(H. pylori) in 1998, there has been no further study to elucidate which component of mastic specifically shows the antimicrobial activity against H. pylori. In this study, we examined which component of mastic gum was responsible for anti-H. pylori activity. We prepared the essential oil of mastic gum and identified 20 constituents by GC-MS analysis. Ten standard components were assayed for anti-H. pylori activity, and it clarified that α-terpineol and(E)-methyl isoeugenol showed the anti-H. pylori activity against four different H. pylori strains that were established from patients with gastritis, gastric ulcer and gastric cancer. These components could be useful to overcome the drug-resistance H. pylori growth in stomach.
|
| Keywords
Mastic gum
Pistacia lentiscus
Anti-Helicobacter pylori
α-terpineol
(E)-methyl isoeugenol
|
| Fund:We thank Mr. Hideo Minobe(Alliance Co., Ltd, Fukuoka, Japan) for supply us the mastic gum and also fruitful discussion. |
|
Issue Date: 11 February 2018
|
|
|
1. V. Herrera, J. Parsonnet, Clin. Microbiol. Infect. 15, 971-976 (2009)
2. L.E. Wroblewski, R.M. Peek Jr, K.T. Wilson, Clin. Microbiol. Rev. 23, 713-739 (2010)
3. S. Kabir, Helicobacter 14, 159-171 (2009)
4. K. Fukase, M. Kato, S. Kikuchi, K. Inoue, N. Uemura, S. Okamoto, S. Terao, K. Amagai, S. Hayashi, M. Asaka, Lancet 372, 392-397 (2008)
5. H. Suzuki, T. Nishizawa, T. Hibi, Future Microbiol. 5, 639-648 (2010)
6. C. Hernandez-Hernandez Ldel, E.C. Lazcano-Ponce, Y. LópezVidal, G.R. Aguilar-Gutiérrez, Salud. Pública. Méx 51, 447-454 (2009). Suppl 3
7. S.F.H. Zaidi, I. Yoshida, F. Butt, M.A. Yusuf, K. Usmanghani, M. Kadowaki, T. Sugiyama, Biol. Pharm. Bull. 32, 631-636 (2009)
8. F.U. Huwez, D. Thirlwell, A. Cockayne, D.A.A. Ala'Alden, New Eng. J. Med. 339, 1946 (1998)
9. C. Koutsoudaki, M. Krsek, A. Rodger, J. Agri. Food Chem. 53, 7681-7685 (2005)
10. P. Magiatis, E. Melliou, A.K. Skaltsounis, I.B. Chinou, S. Mitaku, Planta Med. 65, 749-752 (1999)
11. L. Lauk, S. Ragusa, A. Rapisadra, S. Franco, V.M. Nicolosi, J. Chemother. 8, 207-209 (1996)
12. S. Paraschos, P. Magiatis, S. Mitakou, K. Petraki, A. Kalliaropoulos, P. Maragkoudakis, A. Mentis, D. Sgouras, A.L. Skaltsounis, Antimicrob. Agents Chemother. 51, 551-559 (2007)
13. N. Uemura, S. Okamoto, S. Yamamoto, N. Matsumura, S. Yamaguchi, M. Yamakido, K. Taniyama, N. Sasaki, R.J. Schlemper, New Eng. J. Med. 345, 784-789 (2001)
14. T. Ohkusa, I. Takashimizu, K. Fujiki, S. Suzuki, K. Shimoi, T. Horiuchi, T. Sakurazawa, K. Ariake, K. Ishii, J. Kumagai, T. Tanizawa, Ann. Intern. Med. 129, 712-715 (1998)
15. M. Stolte, S. Eidt, Lancet 342, 568 (1993)
16. A.C. Wotherspoon, C. Doglioni, T.C. Diss, L. Pan, A. Moschini, M. de Boni, P.G. Isaacson, Lancet 342, 575-577 (1993)
17. E.M. El-Omar, I.D. Penman, J.E.S. Ardill, R.S. Chittajallu, C. Howie, K.E.L. McColl, Gastroenterology 109, 681-691 (1995)
18. Therapeutic guideline for Helicobacter pylori infection 2009. Jpn. J. Helicobacter Res. 10 suppl, 1-25. http://www.jshr.jp/. Accessed 15 March 2009
19. E. Rimbara, N. Noguchi, M. Tanabe, T. Kawai, Y. Matsumoto, S.M. Asatsu, Clin. Microbiol. Infect. 11, 307-311 (2005) |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
